Medical Journals, Publishers, and Conflict of Interest

Easley, Thomas J.

doi:10.1001/jama.2017.3421

Cited by 13 publications

(12 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A brief remark on "publication bias" should be made regarding the current existing literature on the subject. 49,50 A thorough literature search was made, but only articles in English were reviewed. It was noticed that literature from export countries emphasized the negative components of medical tourism, whereas import countries focused mostly on its positive aspects.…”

Section: Resultsmentioning

confidence: 99%

Bone Marrow Transplantation and Medical Tourism at Erciyes University - A Single Center Experience

Tiren-Verbeet

Çetın

Alp

et al. 2018

Int J Travel Med Glob Health

View full text Add to dashboard Cite

In its broadest meaning, medical tourism refers to "travel across international borders to receive some form of medical treatment. " 1 Medical tourism emerged in the 1990s when people in developed countries were challenged with high costs and slow service in medical care. As a consequence, people started to look for medical treatment in other countries. 2 Globalization, including cheap and widely available air travel, and easy, cross-border marketing by medical providers accelerated the growth of medical tourism. 3 The terms "medical tourism" and "health tourism" are used interchangeably. 4 "Health tourism" is defined by the World Health Organization (WHO) as the use of services that improve physical or psychological health with the help of mineral water springs, climatic conditions, or medical intervention in an area outside one's place of residence for more than 24 hours and less than one year. 5 Medical tourism is combined with thermal tourism, elderly tourism, and disabled tourism as a part of health tourism. 6 The current review addresses the different aspects of medical tourism in general, describes the development of medical tourism in Turkey, and describes experiences with medical tourism in the Bone Marrow Transplantation Center (BMTC) in Erciyes University, Kayseri. General Considerations on Medical Tourism Several "push" and "pull" factors play roles in the motivation of patients to become a medical tourist. 7-9 The push factors, factors that drive people abroad, are high costs, long waiting periods, and lack of insurance in their homeland. 10 Pull factors, factors that attract people to medical tourism destinations, may include high quality, similar language, and same religion and culture.

show abstract

Section: Resultsmentioning

confidence: 99%

Bone Marrow Transplantation and Medical Tourism at Erciyes University - A Single Center Experience

Tiren-Verbeet

Çetın

Alp

et al. 2018

Int J Travel Med Glob Health

View full text Add to dashboard Cite

show abstract

“…For example, in my own institution, staff from the compliance office routinely examine Open Payments to verify voluntary disclosures by medical faculty (no purposeful omissions have been found thus far). Journal editors and peer reviewers will be able to use the database to verify the disclosures of authors of clinical trials 6 or guidelines. 7 For now the database contains information only on prescribers who practice in the United States, but global regulatory agencies have begun to take notice of our disclosure laws and are expected to follow suit.…”

Section: Verification Of Voluntary Financial Conflict Of Interest Dismentioning

confidence: 99%

The Physician Payments Sunshine Act: Implications and Predictions

Litman

2018

Pediatrics

View full text Add to dashboard Cite

On June 30, 2017, the Centers for Medicare and Medicaid Services released the 2016 Open Payments data, which (as required by the Physician Payments Sunshine Act of the Affordable Care Act) disclose payments and any other "transfers of value" to physicians from commercial entities (https:// openpaymentsdata. cms. gov). This was the third complete year of the availability of this information. It now includes payment information from over 2000 companies that have made ∼40 million payments to over 900 000 physicians for a total of nearly 25 billion dollars. The vast majority of these payments are for relatively small dollar amounts (<$100) related to the provision of food and beverages. Each year, before the release of the information, physicians have the opportunity to refute their own personal data; however, relatively few corrections have been requested or made. At its inception, the Sunshine Act (named in honor of Supreme Court Justice Louis D. Brandeis, who famously wrote, "Sunlight is said to be the best of disinfectants…" 1) was expected to better inform the public about their physicians' financial dealings with pharmaceutical and medical device manufacturers. For example, in an analysis of payments accepted by pediatricians in 2014, it was discovered that most payments were associated with medications that treat attention-deficient/hyperactivity disorder and vaccinations. 2 This may lead parents and child advocates to question the true intent of these types of prescriptions. But, despite this original intention, there has been no indication that the lay public is prepared to use this information to influence their medical decisionmaking. 3 The specific reasons for the payments are unclear, and patients seem to have a general lack of desire to know this type of information about the doctors they already know and trust. Nevertheless, the public availability of these data has proven useful in numerous other ways that give an indication of its future use and the implications it portends for physicians. The most salient of these implications includes the following.

show abstract

“…Specifically, it has been suggested that journal-level financial relationships such as the acceptance of industry advertising revenue, reprint fees, and additional industry printing contracts held by journal parent companies may impact editorial decision-making, creating an environment more favourable to industry-sponsored research. [19][20][21] Editor COI and commercial publishing biases may be of particular concern given recent fears that non-peer-reviewed publications with aCOI are having significant impacts on biomedical research and clinical practice. 25 Certainly, available anecdotal evidence does suggest there may be cause for concern.…”

Section: Introductionmentioning

confidence: 99%

“…24 Furthermore, there are some data available indicating that commercial publishing biases may lead to editors being less diligent in the execution of journal aCOI policies for article authors. [19][20] As greater attention is paid to the potential adverse consequences of aCOI and industry funding on medical research, it is critical that ongoing discussions regarding commercial publishing biases occur in an evidence-rich environment.…”

Section: Introductionmentioning

confidence: 99%

Relationships among Commercial Biases and Author Conflicts of Interest in Biomedical Publishing

Graham

Majdik

Clark

et al. 2020

Preprint

View full text Add to dashboard Cite

Recently, concerns have been raised over the potential impacts of commercial biases on editorial practices in biomedical publishing. Specifically, it has been suggested that commercial biases may make editors more open to publishing articles with author conflicts of interest (aCOI). Using a data set of 128,781 articles published in 159 journals, we evaluated the relationships among commercial publishing biases and reported author conflicts of interest. The 159 journals were grouped according to commercial biases (reprint services, advertising revenue, and ownership by a large commercial publishing firm). 30.6% (39,440) of articles were published in journals showing no evidence of commercial publishing biases. 33.9% (43,630) were published in journals accepting advertising and reprint fees; 31.7% (40,887) in journals owned by large publishing firms; 1.2% (1,589) in journals accepting reprint fees only; and 2.5 % (3,235) in journals accepting only advertising fees. Journals with commercial biases were more likely to publish articles with aCOI (9.2% (92/1000) vs. 6.4% (64/1000), p = 0.024). In the multivariate analysis, only a journal's acceptance of reprint fees served as a significant predictor (OR = 2.81 at 95% CI, 1.5 to 8.6). Shared control estimation was used to evaluate the relationships between commercial publishing biases and aCOI frequency in total and by type. BCa-corrected mean difference effect sizes ranged from -1.0 to 6.1, and confirm findings indicating that accepting reprint fees may constitute the most significant commercial bias. The findings indicate that concerns over the influence of industry advertising in medical journals may be overstated, and that accepting fees for reprints may constitute the largest risk of bias for editorial decision-making.

show abstract

Medical Journals, Publishers, and Conflict of Interest

Cited by 13 publications

References 6 publications

Bone Marrow Transplantation and Medical Tourism at Erciyes University - A Single Center Experience

Bone Marrow Transplantation and Medical Tourism at Erciyes University - A Single Center Experience

The Physician Payments Sunshine Act: Implications and Predictions

Relationships among Commercial Biases and Author Conflicts of Interest in Biomedical Publishing

Contact Info

Product

Resources

About